SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-24-266103
Filing Date
2024-11-26
Accepted
2024-11-26 16:05:51
Documents
11

Document Format Files

Seq Description Document Type Size
1 SC TO-C d832357dsctoc.htm SC TO-C 21028
2 EX-99.1 d832357dex991.htm EX-99.1 9473
3 EX-99.2 d832357dex992.htm EX-99.2 10989
4 GRAPHIC g832357g02g02.jpg GRAPHIC 258667
5 GRAPHIC g832357g04g04.jpg GRAPHIC 285124
6 GRAPHIC g832357g05g05.jpg GRAPHIC 133844
7 GRAPHIC g832357g06g06.jpg GRAPHIC 134051
8 GRAPHIC g832357g07g07.jpg GRAPHIC 121467
9 GRAPHIC g832357g08g08.jpg GRAPHIC 135605
10 GRAPHIC g832357g09g09.jpg GRAPHIC 144961
11 GRAPHIC g832357g10g10.jpg GRAPHIC 144740
  Complete submission text file 0001193125-24-266103.txt   1914621
Mailing Address 1 DNA WAY, MS #24, SOUTH SAN FRANCISCO CA 94080
Business Address C/O THE CORPORATION TRUST, 1209 ORANGE STREET, WILMINGTON, DE 19801 650 225-7893
ROCHE HOLDINGS INC (Filed by) CIK: 0000904566 (see all company filings)

IRS No.: 510304944 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 0000

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Subject) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-91606 | Film No.: 241503671
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)